Danielle Kirsh

Theradaptive announced this week that it received FDA approval to expand its clinical trial for OsteoAdapt SP.

Artivion this week announced it received FDA humanitarian device exemption (HDE) for its AMDS Hybrid Prosthesis.

Anteris Technologies today announced the launch of its initial public offering in the U.S. to advance the development of its DurAVR.

The Acentus transaction follows Henry Schein's acquisition of Shield Healthcare in 2023 and Prism Medical Products in 2021.

Nevro recently announced its Nevro1 SI Joint Fusion System has been shown to outperform traditional surgical approaches in stabilizing the sacroiliac (SI) joint and promote long-term fusion. The research, published in Medical Devices: Evidence and Research, highlights Nevro1’s ability to reduce motion, enhance fusion potential, and minimize invasiveness, making it a groundbreaking option for patients […]

GE HealthCare’s Portrait Mobile continuous monitoring solution is redefining post-surgical care, according to a new study published in the Journal of Clinical Anesthesia. The study, conducted with the Cleveland Clinic, highlights the wearable system’s ability to reduce alarm fatigue while delivering actionable insights. The COSMOS (Continuous Ward Monitoring with the GE HealthCare Portrait Mobile Monitoring […]

The National Institutes of Health (NIH) has unveiled a new artificial intelligence (AI) algorithm designed to more efficiently match potential clinical trial participants to appropriate studies. Known as TrialGPT, the algorithm analyzes patient data to identify relevant clinical trials listed on ClinicalTrials.gov. It offers a potentially transformative tool for accelerating medical research and improving trial […]

Boston Scientific (NYSE: BSX) today announced the completion of its $3.7 billion acquisition of Axonics, Inc. (Nasdaq: AXNX).

Three major investors are calling on Smith+Nephew to explore breaking up parts of its business with a focus on a potential spin off.

Philips announced the first U.S. treatment using its new laser device that combines two peripheral artery disease (PAD) procedures into one.

Cognito Therapeutics announced that its Spectris treatment reduced the Alzheimer's Disease Dependence Score by over 50% in a clinical trial.

Masimo filed a lawsuit against its founder and former CEO Joe Kiani and investment firm RTW Investments, accusing them of illegally manipulating a recent shareholder vote.

Sonablate enrolled its first patient in its clinical trial testing high-intensity focused ultrasound for treatment of incompetent veins.

Electromed today announced it appointed Peter Horwich as VP of marketing, effective immediately. He was most recently at J&J MedTech.

MicroPort recently completed six robot-assisted laparoscopic radical prostatectomy procedures using its MedBot surgical robot in Angola.

Paragonix today announced the first pediatric use of its BAROguard Donor Lung Preservation System in a lung transplant case.

Zoll this week announced it completed the previously announced acquisition of certain assets of Vyaire Medical's ventilator business.

October is a critical time to spotlight the latest innovations in medical devices designed to improve breast cancer diagnosis and treatment.

It has been a blockbuster year for women's health as the federal government and medtech place special focus on the wellbeing of women.

GE HealthCare's MIM Software today announced it received FDA 510(k) clearance for Monte Carlo dosimetry in theranostics.